One year after the Trump administration heralded a significant pledge by dozens of health insurers to streamline the prior authorization process, a growing chorus of patients, advocates, and physicians argues that meaningful improvements remain elusive. Despite promises to reduce administrative burdens and expedite doctor-recommended care, many insurers are reportedly backtracking on commitments, leaving those navigating the healthcare system feeling unheard and underserved.
The initiative, announced in June 2023, was intended to address widespread frustration with prior authorization—a process requiring healthcare providers or patients to obtain insurer approval before certain treatments, tests, or medications can be administered. This hurdle, critics contend, frequently delays or denies necessary care, leading to poorer health outcomes and increased patient anxiety.
While the health insurance industry trade group, AHIP, claims to have eliminated 6.5 million prior authorizations, representing an 11% reduction, skepticism abounds regarding the depth and breadth of these changes. Patient advocates and lawmakers involved in the initial announcement express disappointment, with some labeling the pledge as "performative" and lacking enforceable mechanisms.
The Promise of Reform: A Year in Review
The concept of prior authorization, also known as preauthorization or precertification, has been a fixture in health insurance for decades. Insurers argue it’s a crucial tool for controlling costs, preventing fraud, and ensuring the medical necessity of treatments. However, the process has become increasingly contentious, particularly in the wake of high-profile cases of treatment denials and growing concerns about insurers prioritizing profits over patient well-being.
The June 2023 pledge, which comprised six specific initiatives, was a direct response to mounting public anger and bipartisan concern. At the time of its announcement, Centers for Medicare & Medicaid Services (CMS) Administrator Mehmet Oz acknowledged the intensity of public sentiment, noting, "There’s violence in the streets over these issues." He expressed anticipation for tangible results, a sentiment that now appears to be waning.
According to AHIP, the reported 11% reduction in prior authorizations translates to millions of fewer requests. However, the data provided by the trade group lacks specific details about which services have been removed from the prior authorization process and how these reductions vary among individual insurance companies. Furthermore, AHIP clarified that their figures pertain to medical services and do not include prescription medications, a significant area where prior authorization remains a barrier.
Skepticism Mounts: Advocates Voice Concerns
Despite industry claims of progress, many on the front lines of healthcare delivery and advocacy report little to no improvement. U.S. Rep. Greg Murphy (R-N.C.), a physician and co-chair of the GOP Doctors Caucus, expressed his disillusionment, stating, "It has never been this bad for patients." Murphy, who was present at the pledge’s announcement, criticized the voluntary nature of the agreement, asserting it has "no teeth."
Sabrina Corlette, a research professor at the Center on Health Insurance Reforms at Georgetown University, echoed these sentiments, highlighting the inherent limitations of voluntary industry pledges. "In the absence of clear rules, policies, standards, and mandates," Corlette explained, "insurance companies are going to do what makes sense for them to do financially." This perspective suggests that without regulatory oversight or legally binding commitments, insurers may be disinclined to implement changes that could impact their bottom line.
Patient advocates like Sally Nix, who lives with a chronic disease, describe the pledge as "performative." Nix, a patient advocate who has experienced firsthand the frustrations of navigating prior authorization, recently had a claim for injections to alleviate her chronic nerve pain initially processed by her insurer, only to be retroactively denied. This experience, she argues, underscores the loopholes that allow insurers to circumvent the spirit of the agreement.
The Persistence of Prior Authorization Denials
The core issue remains the burdensome nature of prior authorization, which can involve extensive paperwork, prolonged waiting periods, and the risk of denied claims even after initial approval. This process is applied across a wide spectrum of medical services, from seemingly minor urgent care visits to complex and life-saving cancer treatments.
Chris Bond, a spokesperson for AHIP, defended the practice, calling prior authorization a "vital patient safeguard." However, the tragic killing of UnitedHealthcare CEO Brian Thompson in late 2024, which some linked to the insurer’s aggressive denial practices, amplified public outcry and brought renewed attention to the tactics employed by insurance companies. This incident, coupled with ongoing patient and clinician testimonies, has fueled a growing demand for reform.
Prior authorization reform has emerged as a rare area of bipartisan consensus in healthcare. On July 15, the House Ways and Means Committee unanimously advanced a bill that would mandate Medicare Advantage plans to disclose all services requiring prior authorization and report data on denials and grievances. Such legislative efforts signal a potential shift towards more robust regulatory measures to address the issue.
Insurers’ Backpedaling and the Impact on Patients
The pledge’s promise of improved patient experience appears to be faltering for many. The Betsy Adler and Justin Young family in Stillwater, Minnesota, found themselves embroiled in a protracted battle with their insurer, Medica, shortly after the birth of their daughter, Coco, who was born with a serious heart defect. Despite assurances that their maternal-fetal specialists and hospital were in-network when they switched to Medica, the family began receiving substantial out-of-network charges.
Adler recounted a frustrating ordeal involving a denied referral and a malfunctioning fax machine at the insurer’s office, despite her having a critically ill infant. "I have a critically ill child," Adler stated, reflecting on the emotional toll of fighting with her insurer. "I can either spend my emotional energy at war with Medica, or I can let it go and just enjoy my time with my daughter."
Medica, one of the insurers that initially signed the pledge, declined to comment on the specific case due to patient privacy rules but issued a statement affirming their commitment to working with the family. However, the family’s experience highlights a potential disconnect between the pledge’s intent and the reality on the ground, particularly concerning the promise of a 90-day grace period for continuity of care when switching plans. Experts like Georgetown’s Corlette note that the pledge’s wording may not obligate insurers to cover out-of-network providers at in-network rates, even if they were covered under a previous plan. Ultimately, the Adler and Young family switched insurance companies again to mitigate escalating costs.
Another patient, Jocelyn Austin, 49, of Amherst, New York, faced a similar predicament. After her insurer, Independent Health, approved her stay at an inpatient substance abuse treatment center, she was later billed over $12,000 when the insurer refused to cover the costs. The approval letters themselves contained a disclaimer: "authorization is not a guarantee of claim payment." Independent Health stated the denial was due to services being inconsistent with what was authorized and insufficient medical records, a stance confirmed by an outside consultant. However, Austin argued that the insurer should be held accountable, especially as the explanation of benefits indicated the provider, not the patient, was responsible for the cost.
Technological Hurdles and Transparency Gaps
A key component of the insurer pledge involved adopting new technology to standardize electronic submission of prior authorization requests, moving away from outdated paper-based processes. CMS highlighted that over 50% of prior authorizations were still handled via phone or fax. While AHIP reported an update in April outlining the adoption of new standards by participating insurers, eight of the original signatories did not endorse this technological update: Alignment Health Plan, EmblemHealth, HealthFirst, Independent Health, Medica, MVP Health Care, Point32Health, and SummaCare.
These insurers, whose beneficiaries are spread nationwide, cited various reasons for their hesitation. Alignment Health Plan expressed concerns about the transfer of confidential member health information through a non-standardized process. Medica noted a "significant technical and operational hurdle" in the proposed update. EmblemHealth, however, indicated a commitment to signing on after being questioned. AHIP remains optimistic that more plans will join, emphasizing ongoing efforts to improve the patient experience, while acknowledging that "significant work ahead" remains.
Beyond technological advancements, the pledge also included a commitment to enhance transparency and provide clear, understandable explanations to patients. Yet, according to Mike Gartner, founder of Health Access Innovation, insurers frequently fail to adequately explain denial reasons, providing "inconsistent and contradictory information." Gartner and Rep. Murphy also suspect that insurance companies may be increasingly leveraging artificial intelligence to generate denials, creating "pathways to basically deny things immediately with the hope that people will give up."
Rep. Murphy expressed a desire for executive orders from former President Trump to address these issues, acknowledging the formidable influence of the insurance industry’s lobbying power. The lack of public dashboards to track progress on the pledge, promised by CMS, further fuels concerns about accountability. Federal officials have not responded to inquiries regarding how they are holding insurance companies accountable for their commitments.
The gap between the promise of reform and the lived experiences of patients and providers suggests that voluntary pledges, while a step in the right direction, may be insufficient to enact the systemic changes needed to truly alleviate the burdens of prior authorization. As the healthcare landscape continues to grapple with these challenges, the push for more robust regulatory oversight and greater transparency remains a critical imperative for ensuring timely and equitable access to care.
